Why is Aurobindo Pharma falling/rising?

As of 07-Jul, Aurobindo Pharma Ltd. is experiencing a decline in its stock price, currently at 1,181.50, which reflects a decrease of 7.9 points or 0.66%. The stock has underperformed its sector by 0.58% today and has seen a trend reversal after three consecutive days of gains. Although the stock has shown a positive return of 4.09% over the past week, it has a year-to-date return of -11.51% and a one-year return of -9.41%. The company maintains a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.1, indicating that it is trading at fair value compared to its peers. Additionally, the stock has high institutional holdings at 41.57%, suggesting confidence from larger investors despite the recent price drop.
In the broader market context, Aurobindo Pharma's recent performance contrasts with the benchmark Sensex, which has shown a slight decline of 0.20% over the past week and a positive return of 6.79% year-to-date. This indicates that while Aurobindo Pharma has outperformed the benchmark in the short term, its overall year-to-date performance lags significantly behind. The rising investor participation, as evidenced by a 31.32% increase in delivery volume, may suggest underlying interest in the stock, but the recent price decline reflects broader market pressures and the company's struggles to maintain consistent growth, as indicated by its negative returns over the past year.